“Useful, safe and cost-saving, biosimilar drugs are struggling to find a place in the city”

Tribune. The substitution in pharmacies of a biological drug by its biosimilar equivalent is debated today as it was twenty years ago for generics. Several representatives of the profession are committed in favor of adapted patient support and are calling for changes in legislation. It was just a year ago, in the heart of the first confinement: an IFOP survey testified to the growing attachment of the French to their dispensary pharmacist. 97% of them trust us!

Since then, the major role played by pharmacists in the fight against the epidemic has only reinforced the vision of the pharmacy as a place of health. While the Ministry of Health has just opened a consultation on the development of biosimilar drugs, the involvement of pharmacies seems obvious to us.

Article reserved for our subscribers Read also In the battle between biosimilars and biomedicines, the Ministry of Health seeks a consensus

We want to be able to support patients and strengthen their access to treatment. Less expensive, biosimilars are the equivalent of reference biological drugs as generics are for chemical drugs. They are used in the treatment of serious pathologies, such as diabetes, certain cancers or inflammatory diseases.

Anachronistic regulations to change

Useful, safe and providing savings for our health system, which needs them, these drugs are struggling to find a place in the city, while they are already commonly used in hospitals. Following the example of the National Academy of Pharmacy which recently took a position, no scientific argument today opposes the substitution of these treatments in pharmacies!

Article reserved for our subscribers Read also Innovation in health: a 7 billion euro plan to make up for twenty years of delays

However, the regulations, now anachronistic, do not yet authorize the substitution of the pharmacy of a biological drug by its biosimilar. A situation that we want to see evolve quickly, for the benefit of patients, access to care, and security of supplies.

Article reserved for our subscribers Read also Pharmacists hope to “resume as soon as possible” vaccination against Covid-19

Of course, such a reform must be organized. Patients on biological medication, who often suffer from chronic illnesses, should be able to benefit from specific support and monitoring. They must be properly informed about the drug offered to them, how to use it and its potential impact on daily life.

Pharmacists have always responded

The pharmacist is legitimate today to play this role of advice and support, in conjunction with the prescriber. A local health actor for patients, accessible at any time, he has in-depth knowledge of the overall pathological context of his patients.

You have 34.52% of this article left to read. The rest is for subscribers only.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.